Atesoglu, E. B. Et Al. 2016. Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , no.3 , 248-251.

Atesoglu, E. B., TARKUN, P., DEMİRSOY, E., GEDÜK, A., MEHTAP, Ö., BATMAN, A., ... KAYA, F.(2016). Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis. CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , no.3, 248-251.

Atesoglu, Elif Et Al. "Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis," CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , no.3, 248-251, 2016

Atesoglu, Elif B. Et Al. "Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , no.3, pp.248-251, 2016

Atesoglu, E. B. Et Al. (2016) . "Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis." CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS , no.3, pp.248-251.

@article{article, author={Elif Birtas Atesoglu Et Al. }, title={Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP): Potential Involvement of PD-1 Pathway in ITP Immunopathogenesis}, journal={CLINICAL AND APPLIED THROMBOSIS-HEMOSTASIS}, year=2016, pages={248-251} }